Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center study

Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center study

Background : Previous studies have recommended a 2- to 5-year waiting time prior to kidney transplantation (KT) in patients with end-stage renal disease (ESRD) and symptomatic renal cell carcinoma (RCC) and no delay for incidental early-stage RCC. Data on Asian KT recipients are unavailable.Methods...

Full description

Bibliographic Details
Main Authors: Keun Hoi Park, Jung A Yoon, Hak Soo Kim, Hyosang Kim, Su-Kil Park, Young Hoon Kim, Bumsik Hong, Dalsan You, In Gab Jeong, Chung Hee Baek
Format: Article
Language:English
Published: The Korean Society of Nephrology 2019-12-01
Series:Kidney Research and Clinical Practice
Subjects:
end-stage renal disease
kidney transplantation
recurrence
renal cell carcinoma
survival
Online Access:https://doi.org/10.23876/j.krcp.19.078

Internet

https://doi.org/10.23876/j.krcp.19.078

Similar Items